Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash and cash equivalents	$ 3,264,429	$ 20,729,983
Initial term for POC	22 years
Initial term for Central Lab	5 years
Upfront payment	$ 13,000,000.0	10,000,000.0
Milestone amount recognized	28,000,000.0
Deferred revenue	106,600	23,000,000.0
Amount in excess of FDIC limit	1,125,750	15,220,237
Accumulated other comprehensive loss	385,631	243,940
Research and development expenses	14,400,000	19,600,000
Impairment losses	0	0
Accounts receivable	$ 31,735	$ 0
Concentration of credit risk	67.00%	61.00%
Warrants And Options [Member]
Potentially dilutive securities excluded from the computation of EPS	42,572,283	197,021
Belgian Deposit Guarantee [Member]
Deposits/cash in excess of insured limits	$ 820,066	$ 4,227,147
Singapore Deposit Insurance [Member]
Deposits/cash in excess of insured limits	140,289	107,349
UK Deposit Protection Scheme [Member]
Deposits/cash in excess of insured limits	356,985	320,124
Heska Corporation [Member]
Deferred revenue	$ 22,900,000	$ 23,000,000.0